Stock Trend Analysis Report
Prepared for you on Wednesday, August 10, 2022.
Atea Pharmaceuticals, Inc. - common stock (NASDAQ:AVIR)
Long-Term Uptrend (+90) - AVIR is in a strong uptrend that is likely to continue. While AVIR is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid AVIR?
MarketClub looks at technical strength and momentum to determine if the timing is right for AVIR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for AVIR
The long-term trend has been UP since May 17th, 2022 at 7.5012
The intermediate-term trend has been UP since Jul 5th, 2022 at 7.5100
The short-term trend has been UP since Aug 1st, 2022 at 8.2700
Smart Scan Analysis for AVIR
Based on our trend formula, AVIR is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|52wk High||46.9099||52wk High Date||2021-10-04|
|52wk Low||5.31||52wk Low Date||2022-05-09|
|Average Volume||349,660||Shares Outstanding||83,226|